Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40007694
Localisation
Spain
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
10/10/2024
Statut
Classification
1.5°C
Année cible
2030
Grifols commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2022 base year.* Grifols also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, fuel- and energy-related activities, and upstream transportation and distribution 25% within the same timeframe. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
ES0171996087
LEI
959800HSSNXWRKBK4N60
Source : Science Based Targets initiative | Données publiques